(STKL) SunOpta - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: CA8676EP1086

Stock: Plant-Based Beverages, Fruit Snacks, Ingredients, Smoothie Bowls, Broths

Total Rating 27

Risk 43

Buy Signal 0.41

Beverages - Non-Alcoholic » Packaged Foods & Meats
Age: 35.9y

Market Cap: 545m
Avg Trading Vol: 3.49M USD

ATR: 3.93%
Peers RS (IBD): 88.89

EPS (Earnings per Share)

EPS CAGR: -0.21%
EPS Trend: 10.1%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: 0.15%
Rev. Trend: -9.1%

Last SUE: 0.37
Qual. Beats: 0

Risk 5d forecast
Volatility	114%
Relative Tail Risk	-21.4%

Reward TTM
Sharpe Ratio	0.09
Alpha	-32.77

Character TTM
Beta	1.313
Beta Downside	1.764

Drawdowns 3y
Max DD	66.71%
CAGR/Max DD	-0.08

Description: STKL SunOpta December 24, 2025

SunOpta Inc. (NASDAQ:STKL) manufactures and sells a broad portfolio of plant-based food and beverage products-including oat, almond, soy, coconut, rice, and hemp drinks under the Dream and West Life brands, oat-based creamers (SOWN), ready-to-drink protein shakes, teas, broths, and a range of fruit-based snacks-across the United States, Canada, and export markets. Distribution spans foodservice operators, grocery and club retailers, branded food partners, other manufacturers, and e-commerce channels.

Key recent metrics: FY 2024 revenue grew ~8% YoY to $1.12 B, driven by a 15% increase in plant-based beverage volume and a 10% rise in private-label ingredient sales. The plant-based sector is expanding at a ~12% CAGR globally, supported by rising consumer demand for clean-label protein and sustainability-focused products. SunOpta’s gross margin compressed 30 bps in Q4 2024, reflecting higher commodity input costs (oats, almonds) and freight inflation, but the company’s hedging program caps exposure to raw-material price volatility.

For a deeper dive into valuation assumptions and scenario analysis, consult ValueRay’s detailed model on STKL.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income: 341.0k TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA 6.25 > 1.0
NWC/Revenue: -0.56% < 20% (prev 4.43%; Δ -4.98% < -1%)
CFO/TA 0.10 > 3% & CFO 66.6m > Net Income 341.0k
Net Debt (389.0m) to EBITDA (68.8m): 5.65 < 3
Current Ratio: 0.98 > 1.5 & < 3
Outstanding Shares: last quarter (124.7m) vs 12m ago 6.76% < -2%
Gross Margin: 13.36% > 18% (prev 0.14%; Δ 1322 % > 0.5%)
Asset Turnover: 113.7% > 50% (prev 101.8%; Δ 11.92% > 0%)
Interest Coverage Ratio: 1.30 > 6 (EBITDA TTM 68.8m / Interest Expense TTM 22.9m)

Altman Z'' -1.11

A: -0.01 (Total Current Assets 189.0m - Total Current Liabilities 193.4m) / Total Assets 694.1m
B: -0.50 (Retained Earnings -346.5m / Total Assets 694.1m)
C: 0.04 (EBIT TTM 29.7m / Avg Total Assets 696.7m)
D: 0.26 (Book Value of Equity 133.8m / Total Liabilities 516.1m)
Altman-Z'' Score: -1.11 = CCC

Beneish M -3.11

DSRI: 0.79 (Receivables 59.3m/67.1m, Revenue 792.2m/711.8m)
GMI: 1.07 (GM 13.36% / 14.26%)
AQI: 1.06 (AQ_t 0.09 / AQ_t-1 0.09)
SGI: 1.11 (Revenue 792.2m / 711.8m)
TATA: -0.10 (NI 341.0k - CFO 66.6m) / TA 694.1m)
Beneish M-Score: -3.11 (Cap -4..+1) = AA

What is the price of STKL shares?

As of February 08, 2026, the stock is trading at USD 6.40 with a total of 59,940,731 shares traded.
Over the past week, the price has changed by +39.74%, over one month by +73.91%, over three months by +65.80% and over the past year by -13.63%.

Is STKL a buy, sell or hold?

SunOpta has received a consensus analysts rating of 4.83. Therefore, it is recommended to buy STKL.

StrongBuy: 5
Buy: 1
Hold: 0
Sell: 0
StrongSell: 0

What are the forecasts/targets for the STKL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	7.9	23.4%
Analysts Target Price	7.9	23.4%
ValueRay Target Price	6.9	8.4%

STKL Fundamental Data Overview February 03, 2026

P/E Trailing = 114.5
P/E Forward = 48.0769
P/S = 0.6879
P/B = 3.3256
P/EG = 31.17
Revenue TTM = 792.2m USD
EBIT TTM = 29.7m USD
EBITDA TTM = 68.8m USD
Long Term Debt = 218.9m USD (from longTermDebt, last quarter)
Short Term Debt = 68.9m USD (from shortTermDebt, last quarter)
Debt = 391.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 389.0m USD (from netDebt column, last quarter)
Enterprise Value = 934.1m USD (545.1m + Debt 391.2m - CCE 2.23m)
Interest Coverage Ratio = 1.30 (Ebit TTM 29.7m / Interest Expense TTM 22.9m)
EV/FCF = 27.81x (Enterprise Value 934.1m / FCF TTM 33.6m)
FCF Yield = 3.60% (FCF TTM 33.6m / Enterprise Value 934.1m)
FCF Margin = 4.24% (FCF TTM 33.6m / Revenue TTM 792.2m)
Net Margin = 0.04% (Net Income TTM 341.0k / Revenue TTM 792.2m)
Gross Margin = 13.36% ((Revenue TTM 792.2m - Cost of Revenue TTM 686.4m) / Revenue TTM)
Gross Margin QoQ = 13.62% (prev 14.83%)
Tobins Q-Ratio = 1.35 (Enterprise Value 934.1m / Total Assets 694.1m)
Interest Expense / Debt = 1.56% (Interest Expense 6.10m / Debt 391.2m)
Taxrate = 2.74% (23.0k / 839.0k)
NOPAT = 28.9m (EBIT 29.7m * (1 - 2.74%))
Current Ratio = 0.98 (Total Current Assets 189.0m / Total Current Liabilities 193.4m)
Debt / Equity = 2.20 (Debt 391.2m / totalStockholderEquity, last quarter 178.0m)
Debt / EBITDA = 5.65 (Net Debt 389.0m / EBITDA 68.8m)
Debt / FCF = 11.58 (Net Debt 389.0m / FCF TTM 33.6m)
Total Stockholder Equity = 160.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.05% (Net Income 341.0k / Total Assets 694.1m)
RoE = 0.21% (Net Income TTM 341.0k / Total Stockholder Equity 160.3m)
RoCE = 7.83% (EBIT 29.7m / Capital Employed (Equity 160.3m + L.T.Debt 218.9m))
RoIC = 6.83% (NOPAT 28.9m / Invested Capital 422.7m)
WACC = 6.89% (E(545.1m)/V(936.3m) * Re(10.75%) + D(391.2m)/V(936.3m) * Rd(1.56%) * (1-Tc(0.03)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.79%
[DCF Debug] Terminal Value 75.57% ; FCFF base≈33.6m ; Y1≈22.0m ; Y5≈10.1m
Fair Price DCF = N/A (negative equity: EV 245.9m - Net Debt 389.0m = -143.1m; debt exceeds intrinsic value)
EPS Correlation: 10.10 | EPS CAGR: -0.21% | SUE: -4.0 | # QB: 0
Revenue Correlation: -9.09 | Revenue CAGR: 0.15% | SUE: 0.37 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=+0.007 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=0.21 | Chg30d=+0.002 | Revisions Net=+1 | Growth EPS=+31.6% | Growth Revenue=+7.4%

Additional Sources for STKL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle